Short-acting β₂-agonist prescription patterns in patients with asthma in Turkey: results from SABINA III.

ABSTRACT:

Background

Over-reliance on short-acting β₂-agonists (SABAs) is associated with poor asthma outcomes. However, the extent of SABA use in Turkey is unclear owing to a lack of comprehensive healthcare databases. Here, we describe the demographics, disease characteristics and treatment patterns from the Turkish cohort of the SABA use IN Asthma (SABINA) III study.

Methods

This observational, cross-sectional study included patients aged ≥ 12 years with asthma from 24 centres across Turkey. Data on sociodemographics, disease characteristics and asthma treatments were collected using electronic case report forms. Patients were classified by investigator-defined asthma severity (guided by the 2017 Global Initiative for Asthma [GINA]) and practice type (primary/specialist

SUBMITTER: Yorgancıoglu A 

PROVIDER: S-EPMC9161536 | biostudies-literature | 2022 Jun

REPOSITORIES: biostudies-literature